Biocept Inc. buy Maxi_Scalibusa
Start price
21.01.21
/
50%
€147.00
Target price
21.01.22
€3,000.0
Performance (%)
-48.16%
End price
22.01.22
€76.20
Summary
This prediction ended on 22.01.22 with a price of €76.20. The BUY prediction by Maxi_Scalibusa for Biocept Inc. performed very badly with a performance of -48.16%. Maxi_Scalibusa has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Biocept Inc. | - | - | - | - |
| iShares Core DAX® | -0,38 % | 2,61 % | 11,34 % | 61,27 % |
| iShares Nasdaq 100 | -0,41 % | -2,00 % | 5,35 % | 90,63 % |
| iShares Nikkei 225® | 1,84 % | 9,39 % | 33,53 % | 67,98 % |
| iShares S&P 500 | -0,71 % | -0,48 % | 2,51 % | 62,52 % |
According to Maxi_Scalibusa what are the pros and cons of Biocept Inc. for the foreseeable future?
Pros
Could be very worthwhile Investment >20% year
Cons
Comments by Maxi_Scalibusa for this prediction
In the thread Biocept Inc. diskutieren
In the thread Trading Biocept Inc.
Die von Maxi_Scalibusa gewählte maximale Laufzeit wurde überschritten